Lead Editor:
Dr Muhammer Ergenç,
Marmara University School of Medicine,
Turkey
Thyroid cancer encompasses a diverse set of conditions, ranging from simple nodules to treatable malignancies, and even to highly aggressive variants. The interplay between the genetics, biology, and clinical aspects of thyroid cancer is intricate, with genotype-phenotype correlations aiding in its examination. The purpose of this compilation is to cast a spotlight on the prevailing insights and emerging knowledge regarding thyroid Cancer. Submissions of original research, review articles, commentaries, or comprehensive literature reviews on this subject are invited. This collection aims to cater to those interested in both straightforward and intricate cases of thyroid cancer. Keywords: Thyroid cancer, Neoplasm, Papillary thyroid cancer, Follicular thyroid cancer, Medullary thyroid cancer, Differentiated thyroid cancer, Anaplastic thyroid cancer, Thyroidectomy, Endocrine system surgical procedure, Radioactive iodine therapy, Microcarcinoma, Active surveillance, Intratumoral heterogeneity, Thyroid genomics, Thyroid transcriptomics, Predictive biomarkers, Thyroid cancer incidence, Molecular epidemiology, Thyroid cancer and radiation, Thyroid nodules and thyroid cancer, Intraoperative nerve monitoring, Thyroid Nodule Evaluation, Papillary Carcinoma, Follicular Carcinoma, Oncocytic Carcinoma, Medullary Carcinoma, Anaplastic Carcinoma, Advanced Thyroid Carcinoma, Tumor heterogeneity, Radioiodine therapy, Acquired resistance, Germline susceptibility, Immunotherapy, Targeted therapy
Submission deadline:
19/07/2026
|
Views:
